Theragnostics Ltd.
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://theragnostics.com
Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Theragnostics Ltd
- Target Recruit Count
- 67
- Registration Number
- NCT06650605
- Locations
- π¬π§
University College London Hosptial, London, United Kingdom
π¬π§University Hospital Southampton, Southampton, United Kingdom
68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2020-06-24
- Lead Sponsor
- Theragnostics Ltd
- Target Recruit Count
- 49
- Registration Number
- NCT03617588
- Locations
- π¬π§
St Bartholomew's Hospital (PIC), London, United Kingdom
π¬π§Royal Free Hospital (PIC), London, United Kingdom
π¬π§University College Hospital London, London, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath